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Cortical development is a complex amalgamation of proliferation, migration, differentiation,
and circuit formation. These processes follow deﬁned timescales and are controlled by a
combination of intrinsic and extrinsic factors. It is currently unclear how robust and ﬂexible
these processes are and whether the developing brain has the capacity to recover from
disruptions.What is clear is that there are a number of cognitive disorders or conditions that
are elicited as a result of disrupted cortical development, although it may take a long time
for the full pathophysiology of the conditions to be realized clinically.The critical window for
the manifestation of a neurodevelopmental disorder is prolonged, and there is the potential
for a complex interplay between genes and environment.While there have been extended
investigations into the genetic basis of a number of neurological and mental disorders, lim-
ited deﬁnitive associations have been discovered. Many environmental factors, including
inﬂammation and stress, have been linked to neurodevelopmental disorders, and it may
be that a better understanding of the interplay between genes and environment will speed
progress in this ﬁeld. In particular, the development of the brain needs to be considered
in the context of the whole materno-fetal unit as the degree of the metabolic, endocrine,
or inﬂammatory responses, for example, will greatly inﬂuence the environment in which
the brain develops. This review will emphasize the importance of extending neurodevel-
opmental studies to the contribution of the placenta, vasculature, cerebrospinal ﬂuid, and
to maternal and fetal immune response. These combined investigations are more likely
to reveal genetic and environmental factors that inﬂuence the different stages of neuronal
development and potentially lead to the better understanding of the etiology of neurological
and mental disorders such as autism, epilepsy, cerebral palsy, and schizophrenia.
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INTRODUCTION
The development of the brain is determined by a complex inter-
play of intrinsic genetic programs and environmental interactions
and in utero depends additionally on numerous materno-fetal
interactions. Circulation,oxygenation,metabolic interactions, and
immune responses are all orchestrated between the fetus and
the mother and largely work in harmony. However, when these
interactions malfunction, they could contribute to developmental
abnormalities. The unfolding genetic program of cortical devel-
opment is inﬂuenced by these environmental factors in a highly
complex fashion. While the developing brain is kept separate from
the systemic circulatory system by the brain barriers, and the
maternal circulation is separated from the fetal circulation in the
placenta, it is clear that changes in the maternal/intrauterine and
systemic fetal environments may result in modiﬁcations of normal
fetal brain development. Therefore, neurological and mental dis-
orders have an array of pathophysiological hallmarks that reﬂect a
complex etiology. These disorders are typically diagnosed by clin-
ical features, as the genetics and molecular basis of the diseases
are still largely opaque. There is an emerging ﬁeld that studies
these interactions in the context of barrier biology, immunology,
endocrinology, teratology, and developmental neurobiology. The
challenge is to relate the genetic and molecular program of neu-
rodevelopment to the various insults (including fetal alcohol and
drug exposure, inﬂammation and hypoxic-ischemia) for the bet-
ter understanding of the pathophysiological-mechanisms of these
developmental disorders. The aim of this review is to discuss the
normal cortical developmental program within the context of the
developing fetal and maternal environments and give insights to
somepotential environmental-genetic interactions that contribute
to neurodevelopmental disorders. Of particular interest is the pos-
sibility that one environmental insult could contribute to multiple
diseases, depending on the stage of brain development affected.
For example, maternal alcohol consumption or infection can have
a speciﬁc time window when the consequences are more severe.
For the purpose of this review we divide development into four
stages. The ﬁrst three correspond to key periods in neurogenic
development: (i) proliferation, (ii) migration, and (iii) initial dif-
ferentiation. In humans this corresponds to (i) 1–7weeks, (ii)
8–15weeks and, weeks 16–26, although the true boundaries of
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these processes are not this absolute. We shall also discuss a fourth
stage, which in humans is from the 26th week into the postna-
tal period. This stage largely represents the inﬂuence of other cell
systems on neuronal functions, such as myelination and activ-
ity dependent circuit formation. Boxes 1 and 2 give summary of
the fundamentals of early cortical development for the general
reader. The concomitant development of different components
of the CNS will be discussed as well as the known pathological
consequences of environmental insults during these periods.
MATERNAL/FETAL ENVIRONMENT
MATERNAL SIGNALING
Fetal development is greatly dependent on the maternal envi-
ronment and it is clear that a spectrum of insults can produce
changes in the fetus that include mild fetal growth restriction,
through to severe birth defects or still birth. A number of mater-
nal complications have been speciﬁcally related to negative fetal
outcomes, including pre-eclampsia, depression, diabetes, infec-
tion/inﬂammation, and extremes in body weight (Barker, 2007;
Hoerder-Suabedissen et al., 2008; Zammit et al., 2009).
Congenital abnormalities, including cardiovascular and neural
tube defects, are more common in offspring of overweight or
diabetic mothers, potentially due to the teratogenic effects of
hyperglycemia and relaxin (Hawdon, 2011). These maternal con-
ditions can also alter both the systemic and central control of
metabolism in the offspring (Meaney et al., 2007; Sirimi and
Goulis, 2010; Gluckman et al., 2011; Hawdon, 2011) and may
even lead to epigenetic modulation of neural genes regulating
Box 1 Fundamentals of cerebral cortical development.
PROLIFERATION
The telencephalon, which later develops into the cortex and basal ganglia, starts to generate neurons in the mouse from approximately
E10.5, with neurogenic divisions occurring from E11–E17 (Rakic and Sidman, 1968). Proliferative cell division occurs ﬁrst at the ventricular
surface (in the ventricular zone,VZ) and then starts basal to this zone, in the subventricular zone (SVZ; Figure 4). As neurogenesis progresses
cell division switches from a symmetric, proliferative division to an increasingly neurogenic division (Konno et al., 2008). Once neurogenesis
is complete, the same pluripotent progenitors produce glia. During this period there is also vascularization of the telencephalon, invasion of
microglia, and migration of GABAergic neurons from the ventral to the dorsal telencephalon (Earle and Mitrofanis, 1997; Parnavelas, 2000;
Stubbs et al., 2009).
The different rounds of division in the proliferative zones are responsible for the “birth” of different cortical neuronal populations, which
migrate to establish the cortical layers. A combinatorial transcription factor signaling speciﬁes the future phenotype of cerebral cortical
neurons (Guillemot et al., 2006; Hevner et al., 2006).The timing of this is largely based on intrinsic genetic programming, as cell populations
grown in vitro will differentiate into layer populations after the same number of divisions as observed in vivo (Shen et al., 2006).
MIGRATION
The cortex develops in an “inside-ﬁrst-outside-last” fashion, with deep cortical layers born ﬁrst, and superﬁcial cortical layers born last (Rakic
and Sidman, 1968). Cells that are born in the VZ or SVZ proliferative zones migrate into the cortical plate (CP) along the basal projections of
the radial glia (Métin et al., 2008). The ﬁrst cell populations to migrate out of the proliferative zones are the cells of the preplate which are
visible as early as E12, and which split to form the marginal zone and the subplate (Marin-Padilla, 1971). Following this, waves of division
occur and differentiating neurons migrate past the subplate to form subsequent layers of cortical pyramidal projection neurons (Bystron
et al., 2008). The contribution of the VZ and SVZ to the cortical layers is a subject of contention. In general it is thought that VZ progenitors
contribute neurons to the lower cortical layers (V and VI) and to the SVZ, while the SVZ is the primary source of upper cortical layers (IV and
II/III; Tarabykin et al., 2001; Wu et al., 2005), but there is evidence for SVZ neurogenesis for all layers (Kowalczyk et al., 2009).
There is a degree of plasticity in the genetically programmed cell fate, where extrinsic signaling factors such as neurotrophins (including
nerve growth factor, brain-derived neurotrophic factor, neurotropin-3, and neurotrophin-4) can alter the differentiation of late generated
neurons (Fukumitsu et al., 2006). The degree of plasticity appears to decrease, and may be restricted (Desai and McConnell, 2000). There
are a number of examples where late born neurons may take on protein expression of early cortical layer subtypes, but still migrate to their
later cortical layer (Fukumitsu et al., 2006).
DIFFERENTIATION
Recent studies have elucidated a large number of molecules that are associated with speciﬁc cortical layers (Guillemot et al., 2006;
Molyneaux et al., 2007; Belgard et al., 2011), in some cases these genes (e.g., Satb2, Ctip2, Fezf2) appear to be involved in fate speciﬁcation
of neuronal precursors, and are expressed in the proliferative zones at the time of layer birth and then continue in the differentiated neuronal
population (Alcamo et al., 2008; Britanova et al., 2008; Chen et al., 2008).
Full maturation of the cortex requires cellular differentiation, target connection, and strengthening.The majority of this process occurs in the
late embryonic and postnatal period in rodents. In humans it can continue into adolescence. The glutamatergic CP neurons will integrate
with the GABAergic interneurons into functional circuits (Fishell and Rudy, 2011).
The early steps of cerebral cortical circuit formation are orchestrated by subplate (Kostovic and Rakic, 1990). In mouse, subplate neurons are
a largely transient population of neurons that sit at the base of the CP, in layer VIb in the postnatal brain (Hoerder-Suabedissen et al., 2009).
The subplate forms the earliest cortical projections and appears to act as a scaffold for the establishment of connections with subcortical
structures, e.g., the thalamus (Allendoerfer and Shatz, 1994; Molnár and Blakemore, 1995). It has recently been hypothesized that these cells
have different roles in the brain depending on the developmental stage, and that earlier in telencephalic development the subplate is key
in guiding thalamic projections, while at later stages the remaining subplate cells may integrate more into cortical networks to orchestrate
the development of the ultimate cortical circuits (Kanold and Luhmann, 2010).
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Box 2 Progenitors of the developing cortex.
As the telencephalic vesicles expand from the neural tube the ventricular surface is composed of neuroepithelial progenitors. These cells
undergo symmetric proliferative divisions to increase the pool of progenitor cells (Breunig et al., 2011). They are considered to be neural
progenitor cells, as their daughter cells are able to produce a number of different cell types (reviewed in Pinto and Götz, 2007). However,
unlike other stem cell populations, the neuroepithelial cells are heterogeneous and appear to be restricted both in number of potential
divisions and the fate of daughter cells (Williams and Price, 1995; Gal et al., 2006; Lui et al., 2011). As the cortex develops, the proliferative
population in the ventricular zone undergoes changes.These changes include a slight loss of the apical-basal polarity that is so characteristic
of the neuroepithelial cells, and are considered to be required for the switch from proliferative to neurogenic divisions (Aaku-Saraste et al.,
1996; Lui et al., 2011).
A number of factors combine over a very short period of development to allow division to switch from symmetric, proliferative division to
asymmetric, neurogenic division (where one progenitor and one neuron are produced from a mitotic event; Sahara and O’Leary, 2009).The
division of the cell contents, and most particularly the apical polarity and adherence components, appears to be responsible for whether
division will be symmetric or asymmetric (Farkas and Huttner, 2008). Current evidence suggests that even distribution of the cell contents,
characterized by vertical mitotic division in the early developing cortex, is associated with symmetric, proliferative division. In comparison,
uneven distribution, visible by an angled or horizontal mitotic cleavage, is associated with asymmetric, neurogenic divisions (Zhong and
Chia, 2008; Fietz and Huttner, 2011).
Another factor that appears important for the switch from proliferative to neurogenic division is the length of the cell cycle.There is clear evi-
dence that radial glial progenitors undergoing neurogenic division have a longer G1 phase than neuroepithelial cells undergoing symmetric,
proliferative divisions, and that experimentally lengthening the G1 phase in neuroepithelial progenitors will induce neurogenesis (Hartfuss
et al., 2001; Lukaszewicz et al., 2002; Calegari et al., 2005; Wilson et al., 2011).
Once neurogenesis has started in the VZ, basal progenitor cells can also be observed in the SVZ. Basal progenitors have lost their apical
projections and undergo division at the basal margin of theVZ.They typically undergo symmetric, neurogenic proliferation and are regulated
by a different set of transcription factors, includingTbr2 (Noctor et al., 2004; Hevner et al., 2006).
behavior (Keverne, 2010). Maternal psychosocial stress has been
found to result in altered fetal weight, insulin resistance, meta-
bolic, immune and endocrine function, and decreased cognitive
performance (Entringer et al., 2010) which is likely to be mediated
through glucocorticoid exposure and regulation (Meaney et al.,
2007;Harris and Seckl, 2011). Hypoxia,while a normal part of pla-
cental vascularization, can become pathological in pre-eclampsia
(Redman and Sargent, 2005) or inﬂammatory conditions such as
malarial infection (Rogerson and Boeuf, 2007). Chronic intrauter-
ine hypoxia will result in reduced fetal growth and ischemic brain
damage (Redman and Sargent, 2005; Duncan et al., 2006; Roger-
son and Boeuf, 2007; Gunn and Bennet, 2009). Cytokines are also
a normal part of the regulatory system during pregnancy (Orsi
and Tribe, 2008), and like hypoxia, dysregulation of the cytokine
response locally or systemically has been associated with poor
fetal outcome (Orsi and Tribe, 2008). Chorioamnionitis is a well-
characterized maternal inﬂammatory condition, which increases
circulating cytokines and has been associated with developmen-
tal brain damage (Impey et al., 2001). There is clear evidence
that changes in fetal, rather than maternal, inﬂammation corre-
lates more reliably with severity of neurological outcome (e.g.,
Yoon et al., 2000). The contribution of the fetal environment to
neurological damage will be discussed below.
ROLE OF THE PLACENTA
Placental tissue is of trophoblast origin, but has maternal and fetal
compartments, based on the domains of circulating blood. The
umbilical arteries, veins, and the fetal capillaries make up the fetal
circulation,while the maternal blood enters the intervillous spaces
from the spiral arteries and exit via the uterine veins (Schoenwolf
and Larsen, 2009). The cells that border the intervillous space,
including syncytiotrophoblasts and cytotrophoblasts, provide a
barrier between the maternal and fetal circulation (Figure 1) that
change during pregnancy to meet the increased demand of the
growing fetus (Neerhof and Thaete, 2008). The placenta con-
tributes to many aspects of normal fetal development and early
life programming (Murphy et al., 2006), and has been shown
to contribute directly to early brain development by providing
morphogenic serotonin (Bonnin et al., 2011). Monoamine neu-
rotransmitters start to accumulate within the cortex from E17.5
through to P30 in the mouse (Cheng et al., 2010), 5-HT in par-
ticular at the earliest stages of this period. Knockout (KO) of the
monoamine oxidases has been shown to modulate proliferation in
the intermediate progenitor cells within the cortex at E17.5 and in
the progenitor cells within the SVZ at P2 and in the adult (Cheng
et al., 2010). Studies of Bonnin et al. (2011) suggest a new, direct
role for placental metabolic pathways in modulating fetal brain
development. Understanding such maternal-placental-fetal inter-
actions and 5-HT may hold the key to the understanding of the
etiology of some adult mental disorders.
Placental insufﬁciency has generally been retrospectively diag-
nosed following evidence of intrauterine growth restriction
(IUGR; Huppertz et al., 2006), and may partly explain the high
associationbetween IUGRandbrain dysfunction (Rees et al., 2008;
Raikkonen and Pesonen, 2009). Maternal inﬂammation, which
has also been clearly linked to brain damage in the developing
offspring, has been found to cause reduced placental blood ﬂow
and may cause damage through a hypoxic as well as inﬂamma-
tory pathway (Girard et al., 2010). However, low-level continuous
inﬂammation in the fetus can cause brain damagewithout hypoxia
(Duncan et al., 2006). It is generally considered that the placenta
provides a barrier that prevents direct infection of the fetus (Ash-
down et al., 2006; Hutton et al., 2008). However, Dahlgren et al.
(2006) andHsiao andPatterson (2011)have shown thatmaternally
produced IL-6 can be found in the fetal circulation and correlates
with long-term behavioral deﬁcits in the offspring, suggesting that
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FIGURE 1 | Schematic illustration of the fetal environment and placental
structure.The fetus develops in the uterus isolated from the maternal
circulation through the materno-fetal barrier in the placenta. The maternal
blood enters the intervillous spaces from the spiral arteries. There is transfer
from the intervillous space across the placental barrier to the fetal capillary
network that joins the umbilical vessels. The syncytiotrophoblasts,
cytotrophoblasts, and connective tissue that make up the placental
membrane are the key structures of the placental barrier.
inﬂammation is still able to pass from the mother to the fetus
despite this barrier.
FETAL IMMUNE RESPONSE
There is extensive epidemiological and experimental evidence sug-
gesting that the presence of inﬂammatory mediators in the fetal
circulation, particularly those produced by the fetus, are the best
predictors of fetal brain damage (Yoon et al., 2000; Badawi et al.,
2006; Elovitz et al., 2011). The maturity of the fetal immune
response may therefore contribute to the outcome of mater-
nal/intrauterine insults. Circulating inﬂammatory cells, including
T-cells, B-cell, and macrophages, are produced as early as 7 weeks
in humans (approximately E10 in mice; Melchers, 1979; Solvason
and Kearney, 1992; Holt and Jones, 2000). However, T-cell precur-
sors, in particular, are functionally immature at this stage, which
may contribute to abnormally strong innate immune responses
to inﬂection (Haynes et al., 1988; Michaelsson et al., 2006; Zhao
et al., 2008). Antigen presentation is also impaired during devel-
opment, as major histocompatibility complex (MHC) class II
expression is reduced on antigen presenting cells (Jones et al.,
2002) although some accessory proteins may be expressed at adult
levels.
The liver bud is responsible for the production of acute phase
proteins,which occurs fromE16 onward in the rat liver in response
to pro-inﬂammatory cytokines such as IL-6 (Thomas et al., 1990),
and some acute phase proteins (e.g.,α2-macroglobulin) are known
to be expressed already at E12 in the rat liver (Fletcher et al.,
1988). C-reactive protein (CRP) in humans is expressed, and
developmentally regulated, in preterm neonates with or without
placental inﬂammation (Leviton et al., 2011).CRP levels are specif-
ically associated with the severity of cortical growth retardation in
preterm children (Kaukola et al., 2009); other acute phase proteins
are associated with white matter damage (Leviton et al., 2011), but
the evidence for direct pathological effects of acute phase proteins
in cortical development is scarce. However, peptides homologous
to CRP and other acute phase proteins are known to play a role
in synaptic reﬁnement in the developing cortex (Bjartmar et al.,
2006).
ENDOCRINE INTERACTIONS BETWEEN FETUS AND MOTHER
CNS glucocorticoid receptors and thyroid hormone receptors are
expressed from very early in development (Kitraki et al., 1996,
1997); although their level of expression is considerably less than
in adults. Cortical effects of both under- and overexposure to
glucocorticoids have been described in animal models, including
changes in CP size and maturity in a model of maternal adrenalec-
tomy on day 1 of pregnancy (Trejo et al., 1995), and stress during
pre- and postnatal life is associated with a wide variety of neu-
rological disorders (Cirulli et al., 2009; Harris and Seckl, 2011).
Glucocorticoids are intertwined with immune system function as
well, inhibiting inﬂammatory responses and cytokine expression.
Antenatal steroid use has been associated with reduced mortality
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and complications in preterm children (Whitelaw and Thoresen,
2000). However,multiple courses of steroids have also been associ-
ated with reduced brain growth, impaired myelination, and other
abnormalities (Whitelaw andThoresen, 2000). There is substantial
epidemiological evidence to implicate hypothyroidism in devel-
opmental cognitive/behavioral deﬁcits (Zoeller and Rovet, 2004;
Berbel et al., 2009) including impaired visuomotor skills, low IQ,
ADHD, cerebellar dysfunction, and hearing impairment (Ahmed
et al., 2008; Berbel et al., 2009; Patel et al., 2011). Estrogens have
also been implicated in embryonic neurogenesis, (Brinton, 2009),
with an E2 synthesizing enzyme found in the embryonic cortex
and the estrogen receptor-alpha is present on progenitor cells
during cortical neurogenesis (Martínez-Cerdeño et al., 2006). Fur-
thermore, E2 administration rapidly promotes proliferation, and
in utero blockade of estrogen receptors decreases proliferation
of embryonic cortical progenitor cells (Martínez-Cerdeño et al.,
2006).
VASCULAR DEVELOPMENT AND THE BRAIN BARRIERS
The cardiovascular system is the ﬁrst to become functional in the
embryo (Brand, 2003). Due to its high metabolic demands, the
cortex receives profuse blood supply, which initiates as two plexi,
which progressively become less discrete and vascular density is
much more uniform in late gestation (Virgintino et al., 1998; Java-
herian andKriegstein, 2009; Stubbs et al., 2009; Liebner et al., 2011;
Figure 2).
Angiogenesis is controlled by numerous soluble ligands and
their receptors, with some ligands (notably VEGF) playing differ-
ent roles depending on the stage of vessel development (for exten-
sive reviews see Hanahan, 1997; Gaengel et al., 2009; Quaegebeur
et al., 2010). Pericytes are recruited to the vessels via endothelial
platelet-derived growth factor (PDGF). The loss of pericytes leads
to abnormal capillary morphology and microaneurysms (Lindahl
et al., 1997). The developing vasculature is closely associated with
early neurogenic compartments in the telencephalon (Javaherian
FIGURE 2 | Development of vasculature in relation to cortical layering
and cell proliferation in the embryonic cerebral cortex. Left panel show
generalized schematic drawings of the developing cortical blood vessel plexi
at various embryonic (E14, 15, 18, P8) and adult stages. Initially, there are two
dense plexi in the germinal zone (VZ and SVZ) and CP, connected by tangential
blood vessels. By E15, a few blood vessels tangential to the pial surface start
to appear in the intermediate zone (IZ), but this region remains relatively less
vascularized compared with the plexi in the VZ/SVZ and the CP. At E18, toward
the end of the neurogenesis, the ventricular plexus has lost much of its
deﬁnition; and by P8 and adulthood, a more homogeneous structure with
many small parenchymal arteries is present. MZ, marginal zone; SP, subplate;
I–VI represent cortical layers in adult. (A) Association of SVZ blood vessels to
mitotic proﬁles in developing cerebral cortex and ganglionic eminence in an
E14 brain. Blood vessels (revealed with IB4-green) and the mitotic proﬁles
(revealed with pH3-red immunoreactivity) on a low power image of a sagittal
section through the cortex. Scale bar=400μm. CTX=Cerebral cortex.
(B) Higher magniﬁcation of the area indicated by the rectangle in A, illustrate
examples of dividing intermediate progenitor cells (pH3+Tbr2+) that are in
close proximity to the cortical vascular plexi (IB4+). Scale bar=50μm.
Modiﬁed from Stubbs et al. (2009) and Nie et al. (2010).
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and Kriegstein, 2009; Stubbs et al., 2009; Nie et al., 2010; Figure 2),
andmany signalingmolecules are sharedbetween these developing
systems (discussed below).
The CNS vasculature features the added complexity of the
blood-brain barrier (BBB) (Figure 3A),which is required for ionic
and neurotransmitter homeostasis, protection from neurotoxic
agents, and selective provision of nutrients (Neuwelt et al., 2011).
The BBB involves both tight junction formation (the failure of
which critically impairs BBB function; Nitta et al., 2003), as well as
reduced vesicular transport and a speciﬁc asymmetric polarity of
endothelial transporter expression, e.g., GLUT-1 (Dobrogowska
and Vorbrodt, 1999). There is evidence that the ﬁrst penetrating
intraneural capillary (at E10) showed no fenestrations and junc-
tional complexes between endothelial cells (Bauer et al., 1992) and
are impermeable to even very small molecules (Ek et al., 2006).
The brain is also separated from the external environment by the
arachnoid barrier on the surface of the brain and the epithelial bar-
rier at the choroid plexus (Figure 3C), which are also present early
in development (Ek et al., 2001, 2003, 2010; Johansson et al., 2005)
suggesting a functional barrier and protective system. The compo-
sition of the cerebrospinal ﬂuid (CSF) is different in the developing
brain compared to the adult (Dziegielewska et al., 1981), which
appears to be due to a developmentally regulated speciﬁc trans-
fer mechanism across the choroid plexus epithelial cells (Habgood
et al., 1992; Liddelow et al., 2009, 2011) that is important for nor-
mal brain development (Johansson et al., 2008, discussed in more
detail below).
Disruption of the BBB has been identiﬁed in an age-speciﬁc
manner following both systemic and centrally induced inﬂam-
mation. Interestingly, the window of susceptibility appears to be
different for these, depending on the site of inﬂammatory stim-
uli. Systemic inﬂammation caused by LPS injection produces
FIGURE 3 | Schematics of the brain barriers. Barrier interfaces in the brain
are indicated in blue in the schematic diagrams of the blood-brain barrier,
blood-CSF barrier, meningeal barrier, and fetal CSF-brain barrier. The primary
site of the blood-brain barrier (A) is the endothelial cells of the cerebral blood
vessels (E), supported by pericytes (P) and astrocytic endfeet (Ae). In the
choroid plexus (B) the epithelial cells (Ep) are the barrier interface of the
blood-CSF barrier, as the endothelial cells in the stroma are fenestrated. The
meningeal barrier (C) is at the boarder of the arachnoid membrane (Arach) and
the subarachnoid space (SAS). The fetal CSF-brain barrier (D) exists during
early development, at the endfeet of the radial glial progenitors. This forms a
barrier between the CSF and the developing parenchyma. Modiﬁed from
Saunders et al. (2008).
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disruption of the BBB in white matter tracts in the ﬁrst postna-
tal week in rats (Stolp et al., 2005), whereas IL-1β in the striatum
produces a substantial increase in barrier permeability in juvenile
animals, but not neonates or adults (Anthony et al., 1997). Previ-
ous work (Stolp et al., 2005) suggests that the blood-CSF barrier
(Figure 3B) does not have an altered permeability following sys-
temic inﬂammation, however it has been hypothesized that the
function of the choroid plexus epithelial cells may change, altering
the composition of the CSF (discussed below).
TELENCEPHALIC ENVIRONMENT DURING PROLIFERATION,
MIGRATION, AND DIFFERENTIATION
The environment surrounding the developing brain is, therefore,
complicated and the different developmental timetables for organs
and regulatory systems can interact to cause variation in brain
development. The environment within the developing brain can
be described in a similar manner. Many different cell types are
produced within the brain and need to differentiate, migrate, and
integrate effectively to produce normal brain function.
VASCULAR REGULATION AND NEUROGENIC NICHE
The developmental control of the vasculature goes hand-in-hand
with neurogenesis in the brain. There is clear evidence that angio-
genesis follows morphogenic factors such as Dlx1/2, Nkx2.1, and
Pax6 to produce a ventricular vascular plexus that develops in
a ventral-dorsal gradient (Vasudevan et al., 2008). This plexus
extends in the dorsal telencephalon as the SVZ is established
(Vasudevan et al., 2008), and it appears that progenitors within
the SVZ exist within a neurogenic vascular niche (Javaherian and
Kriegstein, 2009; Stubbs et al., 2009; Nie et al., 2010) that has
also been well established in the adult brain (Shen et al., 2008).
There are many similarities and interconnections between cardio-
vascular and cortical development. For instance, the outgrowth
and alignment of blood vessels relies on molecular signals such
as semaphorins and netrins, cues also used within the develop-
ing nervous system (reviewed by Larrivee et al., 2009). One clear
example is VEGF, which is known to be crucial in vascular devel-
opment (Carmeliet et al., 1996) but some isoforms also regulate
proliferation in the neuroepithelium (Darland et al., 2011).
CEREBROSPINAL FLUID
The CSF in the developing brain plays an important role in cere-
bral expansion (Gato and Desmond, 2009). CSF is secreted by
the choroid plexus, which develop from as early as E12 in the rat
(Dziegielewska et al., 2001). The primary role of the choroid plexus
is to secrete and control the composition the CSF and the cellular
mechanisms for CSF secretion, such as aquaporin expression, are
established from the day of choroid plexus appearance (Johansson
et al., 2005). The choroid plexus regulates the protein composi-
tion in the CSF by either production (e.g., TTR, Igf2; Dickson
et al., 1986; Hynes et al., 1988; Southwell et al., 1993) or speciﬁc
transfer from the blood (Habgood et al., 1992; Johansson et al.,
2006; Liddelow et al., 2009), which result in their high concen-
tration within the CSF during early development (Dziegielewska
et al., 2001; Johansson et al., 2008). It has been well established that
the high protein content of developmental CSF is important for
cortical expansion (Gato and Desmond, 2009), but initial exper-
iments only assessed this in terms of providing an osmotic force
for ventricular, and therefore cortical, expansion. However, recent
experiments have conﬁrmed that proteins within the CSF interact
with receptors on the ventricular surface and regulate prolifera-
tion within the VZ (Martin et al., 2006; Lehtinen et al., 2011).
The generally high CSF protein concentration decreases in the
rat at approximately E17 (Johansson et al., 2008), but it is likely
that speciﬁc proteins within in the CSF still occur at high concen-
trations during the embryonic period and continue to inﬂuence
neurogenesis (e.g., Igf2; Lehtinen et al., 2011).
MICROGLIA
Linage tracing has been used to demonstrate that microglia are
derived from the systemic progenitors and migrate into the brain
around E9.5 in the rodent (Ginhoux et al., 2010). Microglia slowly
increase in number within the brain, with higher distribution
density within the meninges and the VZ/SVZ border followed by
increasing density in the CP as gestation continues (Antony et al.,
2011). Microglia are considered to play a role during these early
stages of development in supporting the proliferation of prog-
enitors within the cortex. While depletion of microglia from the
developing brain in PU.1−/− mice (McKercher et al., 1996) is asso-
ciated with grossly normal cortical development up to E16 (when
animals die due to hematopoietic dysfunction) there is some evi-
dence that there is decreased cortical proliferation in the absence
of microglia, which ultimately leads to a reduction in astrocyte
numbers (Antony et al., 2011). At an equivalent stage of develop-
ment, altered microglia function, by a loss-of-function mutation
in the DAP12 gene, also provides evidence that microglia affect
neuronal maturation and later synaptic formation and function
(Roumier et al., 2008).
In the fourth phase of telencephalic development there is a
massive increase in the number of microglia (up to 20-fold) that
can be speciﬁcally observed with an amoeboid phenotype within
white matter tracts (Prinz and Mildner, 2011). Microglia slowly
spread through the entire CNS throughout the postnatal period
and take on a“resting,” ramiﬁed phenotype (Hristova et al., 2010).
During this period, when microglia have previously been con-
sidered to be static, there is evidence that they play a role in
synaptic pruning and may be important for aspects of struc-
tural reorganization associated with LTP and LTD (Schlegelmilch
et al., 2011). Recently, microglia have been shown to engulf and
eliminate synapses during development (Paolicelli et al., 2011).
Microglia activation is considered a natural step in elimination of
juvenile connections, e.g., in the corpus callosumor during normal
formation of the barrel cortex (Berbel and Innocenti, 1988; Maki
Hoshiko,NobuhikoYamamoto and EtienneAudinat et al., unpub-
lished), and has been demonstrated in pathological neural activity
(Avignone et al., 2008) both are highly suggestive of functional
involvement in cortical circuit remodeling. There is evidence that
the chemokine fractalkine (CX3CR1) is important in mediating
microglial synaptic pruning. In KO mice unable to produce the
fractalkine receptor (Cx3cr1KO) there is a decrease in microglial
densities in developing brain regions and newborns had an excess
of dendritic spines and immature synapses, although these changes
were found to be transient (Paolicelli et al., 2011). Interestingly,
mice lacking functional Hoxb8 (a transcription factor that is
involved in the development of the hematopoietic system) exhibit
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obsessive grooming behavior, which is linked to the loss of the
Hoxb8 microglial population in the brain (Chen et al., 2010). This
provides a novel link between microglia and behavioral evidence
of neuropathology.
ASTROGLIAL DEVELOPMENT
During stage 3 of telencephalic development, there is a switch
from neurogenesis to gliogenesis (Figure 4). Experiments using
ﬂuorescence-activated cell sorting and time-lapse microscopy
show radial glia can generate astrocytes as well as neurons (Malat-
esta et al., 2000; Noctor et al., 2004; Box 2). The neuron to glia
switch is reliant on both cell-intrinsic and extracellular cues. Early
in forebrain development the promoters of GFAP and S100B are
methylated, ensuring astrocyte development is repressed (Juliandi
et al., 2010). Demethylation increases the sensitivity to extracel-
lular cues such as developmental cytokines (Molne et al., 2000;
Juliandi et al., 2010). Neurons are known to secrete cytokines
involved in gliogenesis, particularly members of the IL-6 family:
LIF,CNTF,CT1 (Juliandi et al., 2010). Embryonic cortical neurons
can regulate the onset of cortical gliogenesis via cardiothrophin-1
(Barnabe-Heider et al., 2005). This is a neural feedback mech-
anism whereby newly born neurons can instruct precursors to
generate astrocytes via the secretion of cytokines, ensuring that
gliogenesis does not occur until after neurogenesis. The use of
cytokines in regulating the development of glia leaves the pos-
sibility that gliogenesis can be disrupted by additional cytokine
production following an environmental insult such as perinatal
inﬂammation.
Following astrocyte speciﬁcation, precursors migrate to their
ﬁnal positions where they begin the process of terminal differ-
entiation. Astrocytes initially migrate tangentially along white
matter tracts and then move in a radial direction in the gray
matter (Jacobsen and Miller, 2003). The major waves of rodent
CNS synaptogenesis occur during the ﬁrst 2–3weeks of postna-
tal life and astrocytes are known to secrete molecules that induce
synapse formation (Christopherson et al., 2005; Kucukdereli et al.,
2011). Their inﬂuence on synaptic functionmight be stage-speciﬁc
and modulate well described periods of developmental plasticity.
The early experiments by Müller and Best (1989) demonstrated
that the transplantation of astrocytes from the visual cortex of
newborn kittens into the visual cortex of adult cats reinstalls
ocular-dominance plasticity in adult animals.
OLIGODENDROCYTES
Oligodendrocyte precursors are produced from three different
waves of division, from different progenitor populations, primar-
ily in the third and fourth phases of telencephalic development.
The majority of oligodendrocyte precursors originate from the
FIGURE 4 | Pattern of telencephalic development. Schematic
indicating the increasing complexity of the brain over time. Initially
proliferation occurs to increase the size of the progenitor pool (phase 1 of
telencephalon development). As neurogenesis starts, vascular plexi,
supported by pericytes, form and microglia inﬁltrate the brain. A second
proliferative zone in the SVZ forms. Neurons migrate and differentiate
into cortical layers in an inside out manner during phase 2 and 3 of
development. In phase 4 of development, gliogenesis occurs in the
dorsal and ventral telencephalon. GABAergic interneurons increase their
migration into the cortex. There is vascular remodeling and a maturation
and integration of connections between neurons, supported by the
micro and macroglia.
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ventricular zones in the ganglionic eminences of the ventral telen-
cephalon, a brain region that is also responsible for the production
of interneurons (see below). Two prenatal waves of production
occur from this zone in the rodent, with the oligodendrocyte
precursors migrating to the cortex before full maturation and
myelination occurs. A third, postnatal, wave of production occurs
in the dorsal ventricular zone after the completion of neurogenesis
(Kessaris et al., 2006). In both proliferative zones oligodendrocyte
precursors are produced as part of a fate restriction of the neural
stem cells that occurs by a largely epigenetic regulation (Liu and
Casaccia, 2010). The cross-talk that occurs between transcription
factors, which is regulated by DNA methylation or acetylation,
provides an initial support for astroglial genesis, that switches to
support oligodendrogenesis over the developmental period (Liu
and Casaccia, 2010; Rivera et al., 2010). In both the ventral and
dorsal telencephalon,Wnt signaling has been implicated in activat-
ing oligodendrogenesis over the previous astroglial or interneuron
proliferative fates (Langseth et al., 2010; Zhong et al., 2011).
INTERNEURONS
Approximately 25% of cortical neurons are inhibitory GABAergic
interneurons, which arise from precursors in the subpallium and
tangentially migrate into the developing neocortex (Wonders and
Anderson, 2006). The rodent interneurons arise mainly from the
ganglionic eminences (Lavdas et al., 1999; Wichterle et al., 1999;
Anderson et al., 2001; Jimenez et al., 2002; Nery et al., 2002), from
approximately E12.5 until birth (Flames and Marín, 2005). There
is considerable evidence that rodent models do not accurately
reﬂect the complexity of the primate cortex, which likely receives
interneurons from the ventricular zone, SVZ and subpial granular
layer in addition to the GE (Letinic and Rakic, 2001; Letinic et al.,
2002; Wonders and Anderson, 2006; Jones, 2009; Petanjek et al.,
2009). However, this issue in human is not yet resolved (Clowry
et al., 2010; Hansen et al., 2010). The establishment of interneuron
networks in rodents begins a fewdays before the glutamatergic net-
work and continues until postnatal life (Cossart, 2011). The origin
of interneurons, both in terms of their birth date and region of ori-
gin, contributes to determining their electrophysiological proper-
ties andneurochemical characteristics (Butt et al., 2005). Birth date
and phenotype also predict the laminar fate of interneurons in the
rat (Rymar and Sadikot, 2007). Interneuron migration is thought
to be induced by motogenic factors such as neurotrophins and
hepatocyte growth factor; the pattern of interneuron migration
is established by a variety of chemoattractive and chemorepulsive
cues, including stromal-derived factor 1, neuregulins, slit proteins,
and ephrins (Hernandez-Miranda et al., 2010). The correct inte-
gration of interneurons during CNS development is essential for
normal coordinated brain function. Epilepsy and schizophrenia
are two neurodevelopmental conditions that occur, at least in part,
as a result of interneuron dysfunction (discussed below).
CAUSES OF TELENCEPHALIC INJURY
It is clear that many elements contribute to a fully functional
central nervous system, and that dysfunction in one can have
widespread consequences, however establishing etiology of neu-
rodevelopmental disorders has been difﬁcult (see Box 3). Genes
that have been associated with these conditions typically have low
penetrance and may confer risk for a number of distinct clini-
cal conditions. Likewise, a wide number of environmental insults,
such as inﬂammation and hypoxia, have been indicated by epi-
demiological studies to contribute a small but signiﬁcant risk
to many neurological and mental disorders. Gene-environment
interactions or other forms of confounding insults, along with
the developmental windows of susceptibility are now a focus of
current research aiming to explain these observations.
TWO-HIT HYPOTHESIS AND WINDOW OF VULNERABILITY
A “two-hit” hypothesis has been put forward in a number of dis-
eases where onset of disease cannot clearly be linked to a speciﬁc
genetic or environmental insult. In diseases such as schizophrenia
and autism, there is evidence for both genetic contributions and
environmental insults, but neither one accurately predicts disease.
Support for a two, or multiple, hit etiology for these diseases is
particularly strong as limited clear neuropathology has been iden-
tiﬁed that can be linked to one speciﬁc genetic or environmental
insult. Instead, a wide variety of broadly linked functional systems
are effected, including genes involved in synapse formation, cell–
cell signaling, and trophic pathways, and injury widely affecting
GABA, dopaminergic, and glutamatergic transmission (Maynard
et al., 2001). It has been hypothesized that the ﬁrst hit in schiz-
ophrenia may affect neurogenic and cell speciﬁcation pathways,
such as Notch, while the second hit may have a greater effect on
functional integration (Maynard et al., 2001).
The term two-hit hypothesis has also been used to describe the
increased deﬁcit caused by two or more low-level cytotoxic insults,
which combine to produce greater long-term damage. In a basic,
proof of principal study,Genetta et al. (2007) have shown an addi-
tive cytotoxic effect of low dose alcohol and hypoxia exposure in
primary neuron cultures. There have also beenmany studies show-
ing that inﬂammation combined with hypoxia can cause increased
neurological injury. Inﬂammation induced by lipopolysaccharide
injection 4, 6, or 72 h prior to hypoxic-ischemic injury has been
found to signiﬁcantly increase infarct size in postnatal day 7 rats
(Eklind et al., 2001, 2005). Prenatal LPS exposure has also been
associated with increased sensitivity to later hypoxic insult in the
immature brain (Larouche et al., 2005). However, the mechanism
of this sensitivity is confused, and may be due to the priming of
the immune cells (Williamson et al., 2011; Bilbo et al., 2012). In
comparison, inﬂammation as a ﬁrst hit in schizophrenia is pre-
sumed to cause long-term changes in brain structure or function
that occur at a subclinical level and are exposed by a second hit
in later life (Meyer et al., 2005, 2006; Fatemi et al., 2008; Meyer
and Feldon, 2009). Interestingly, there is also some evidence that
insults during early life may contribute to neurodegenerative dis-
ease later in life. For example, inﬂammation during embryology
(E10.5 in themouse) results in loss of dopaminergic neurons in the
basal ganglia, and increased sensitivity to the 6-hydroxydopamine
neurotoxin later in life (Ling et al., 2002, 2004). This substantial
decrease in dopaminergic neurons may also increase the suscepti-
bility of affected individuals to“normal”age-induced cell loss, and
may account for cases of extremely early onset Parkinson’s disease.
Themechanismbywhich environmental insults such as inﬂam-
mation/hypoxia and genetics combine in neurodevelopmental
disease will be discussed below. It is also important to consider
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Box 3 Diagnosis and experimental tools.
EPIDEMIOLOGY
Epidemiological studies linking prenatal insult with later neurodevelopmental disorders are subject to many difﬁculties, including the lim-
itations of retrospective assessment of possible exposure to insult, and the years to decades elapsed between gestational insult and
disease diagnosis. Early studies assessing the association between inﬂuenza and schizophrenia are an example of these difﬁculties, as
assessments were made based on potential exposure to inﬂuenza during gestation (i.e., occurrence of an inﬂuenza epidemic during the
pregnancy), rather than the actual presence of maternal infection (Brown and Derkits, 2010). More recent studies, that have utilized medical
records and analyzed available blood samples, have found a signiﬁcant risk of schizophrenia following inﬂammation in the ﬁrst and second
trimester of pregnancy.With conditions such as cerebral palsy, the successful outcome of epidemiological studies is more attainable. Due to
the relatively early age of clinical diagnosis, as well as multiple neuropathologies that can be identiﬁed with imaging technology, it is possible
for studies such as the ELGANS study (O’Shea et al., 2009; Leviton et al., 2011) to determine the links between multiple environmental
insults, extreme prematurity, and risk of developing cerebral palsy or mental retardation in large cohort groups with well-deﬁned assessment
criteria.
IMAGING
Imagining modalities have been utilized to provide a whole brain view of neurodevelopmental disorders. The results from these studies,
while advantageous, highlight the difﬁculty of determining the etiology of these disorders (Anagnostou and Taylor, 2011). Changes in the
brain are generally subtle, requiring extensive group comparison with carefully controlled age-matched groups, and the origins of changes
in signal are generally difﬁcult to determine. For example, progressive loss of cortical gray matter is observed in cases of child-onset schiz-
ophrenia, but from MRI images it is currently difﬁcult to determine whether these changes are of neuronal origin (e.g., increased synaptic
pruning), or are due to changes in astrocytes, vasculature, or myelination of the affected cortical regions. Histological comparisons from
autopsy may partly aid this analysis, although in the case of schizophrenia samples are generally late-stage disease and confounded by a
variety of treatment and life-style choices (Toga et al., 2006). However, imaging techniques such as MRI, PET, and photo-acoustic ultrasound
are now available with good resolution for small animals.The use of these together with standard histological assessments may allow links
to be made between the structure and function of the brain in animal models and equivalent human clinical conditions.
BEHAVIOR
Deciphering how risk factors act on brain development that result in altered circuits, and subsequently inﬂuence the behavioral symptoms,
is the real challenge of psychiatric research. Endophenotype is a psychiatric concept to divide behavioral symptoms into more stable pheno-
types with a clear genetic connection. However, the involvement of distinct genes, which could underlie certain endophenotypic traits, in
neural development is very often not known. Systematically examining the composition, morphology, connectivity of the brain is very rarely
linked up to particular structure or cell types that make up circuits underlying behavioral endophenotypes in animal models. Nevertheless,
animal models of behavior will remain valuable tools for the investigation of altered brain circuits (Amann et al., 2010).
the timing of insult in relation to the stages of brain development.
The term“window of vulnerability” is commonly used when con-
sidering developmental neurological injury. However, it is not yet
clear if this vulnerability is intrinsic to speciﬁc periods of develop-
ment (e.g., proliferation or synapse formation), and therefore may
move from region to region along with the normal developmen-
tal gradients of these processes. Alternatively, it has been suggested
that different cells may become selectively vulnerable to damage as
a result of the different intrinsic maturation process. An example
of this are subplate neurons, which are thought to have increased
vulnerability to injury in the prenatal human due to an early birth
date and therefore earlier maturation of glutamate receptor pop-
ulations (Furuta and Martin, 1999; Talos et al., 2006; Nguyen and
McQuillen, 2010). This leads to increased sensitivity to excitotox-
icity at a time of development where there is an increased risk of
hypoxic-ischemic injury.
Cerebral palsy provides an example of the consequence of the
stage of brain maturity at the time of insult on subsequent neu-
ropathology. Injury at term, e.g., umbilical cord asphyxia during
delivery, causes cerebral palsy with a typical pattern of gray mat-
ter loss, as well as damage to the hippocampus and cerebellum.
Whereas preterm injury, leading to cerebral palsy, is generally
associated with white matter and subcortical gray matter dam-
age (Gunn and Bennet, 2009; Volpe, 2009). There are a few
confounding maturation steps that underlie these differences in
regional damage.Whitematter is beginning to bemyelinated in the
preterm period in humans, and speciﬁc populations of precursor
oligodendrocytes have been shown to be particularly susceptible
to damage, which corresponds to this period. In contrast, areas
of term damage are typically described as “watershed” damage,
indicating that these brain regions are at the edge of the vascu-
lar zones, therefore increasing susceptibility to hypoxic damage
(Gunn and Bennet, 2009; Volpe, 2009). In preterm white matter,
similar watershed regions have been suggested due to the pat-
tern of vascular development, however, it was determined that
differences in vascular blood ﬂow could not account for the differ-
ent magnitude of damage in the region (McClure et al., 2008).
Therefore, the different patterns of damage have been associ-
ated with selective sensitivities of developing cells at the time
of insult. This is an example whereby different insults, at differ-
ent stages of brain development can cause distinct, but related
neuropathologies which contribute to the one clinical diagnosis.
GENETICS
The genetic regulation of brain development is extremely compli-
cated, with a wide number of genes regulating proliferation and
differentiations states, as well as more subtle aspects of neurolog-
ical function, such as signaling pathways and receptor function.
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Altered neurological development leads to a variety of subtle or
complicated behavioral dysfunctions, from slight mental retarda-
tion to gross motor and cognitive deﬁcits. A number of genetic
variants have been associated with these general disorders, as
well as speciﬁc neurodevelopmental diseases. For example, a large
number of gene variants associated with increased risk of autism
spectrum disorders (ASDs) have a wide range of functions in
the central nervous system and are associated with a variety of
other neurological disorders (Aldinger et al., 2011). Congenital
neurological disorders due to genetic variation may have a sub-
tle neuropathology, such as for autism, or may be associated with
gross changes in the brain, such as for microcephaly.
Primary recessive microcephaly affects approximately 1:10,000
people, and is classiﬁed based on small brain size and altered
gyrations of the cerebral cortex (either lissencephaly or polymicr-
ogyria) that are present at birth (Abuelo, 2007). The genetic basis
of this condition has been clearly linked to a number of mutations
that all affect neural progenitors (Buchman et al., 2011; Mahmood
et al., 2011; Poulton et al., 2011). The function of the abnormal
spindle microcephaly (APSM) gene may occur directly through
the regulation of the mitotic spindle and indirectly by modulating
theWnt signaling pathway (Buchman et al., 2011). Tbr2 is another
gene that normally regulates proliferation within the developing
cortex, where gene manipulation has been associated with micro-
cephaly in experimental models (Arnold et al., 2008; Sessa et al.,
2008) and in clinical cases of microcephaly in humans (Baala et al.,
2007).
Inhibitory transmission is crucial for normal cortical func-
tion and its defects are associated with a variety of neurological
and psychiatric disorders, including autism (Levitt, 2005), schiz-
ophrenia (Lewis et al., 2005), and epilepsy (Noebels, 2003). The
pathobiology of schizophrenia remains poorly understood, but
genetic and anatomical studies are beginning to indicate the com-
plicated neuropathology. Recently identiﬁed epigenetic changes
in GAD67 and reelin genes support the GABAergic hypothesis
of schizophrenia (O’Connell et al., 2011). Post-mortem studies
have also revealed reductions in inhibitory neurotransmission
markers in schizophrenics (Volk et al., 2000); although this may
not be the case in all subjects and modern hypotheses focus on
abnormal interneuronal connectivity rather than simply insuf-
ﬁcient numbers of cells (Marín, 2012), these observations are
nonetheless suggestive of developmental abnormalities (Harrison
and Weinberger, 2005). For instance, Disrupted in Schizophre-
nia 1 (DISC1) mutations are known to cause familial schizo-
phrenia (Millar et al., 2000). DISC1 appears to function in cell
migration among other pathways, as mouse models with DISC1
inhibition show reduced migration of both developing pyrami-
dal cells (Kamiya et al., 2005) and MGE-derived interneurons
(Steinecke et al., 2012). Neuregulin 1 (NRG1) and its receptor
ErbB4, both schizophrenia risk genes (Stefansson et al., 2002,
2003), are also involved in migration: ErbB4 mutant mouse
cerebellar cultures exhibit reduced granule cell migration along
radial glia (Rio et al., 1997) and electroporations of dominant-
negative ErbB4 into the MGE prevent migration to the cortex,
whereas heterologous expression of NRG1 induces migration
toward the expressing cells in vitro and in vivo (Flames et al., 2004).
There are numerous other examples of development-related
schizophrenia risk gene such as Tcf4 and CNTNAP2 (Blake
et al., 2010). However, as most risk-conferring polymorphisms
are intronic, their functions and relevance to disease mecha-
nisms are not well characterized. Moreover, DISC1 has not been
demonstrated to have signiﬁcant association with schizophre-
nia in genome-wide association studies (GWAS). It is likely that
there are numerous endophenotypes in schizophrenia with dif-
ferent underlying genetic causes, but these have not yet been well
deﬁned.
One of the GWAS results for schizophrenia has been the
MHC region (Stefansson et al., 2009), suggesting the involve-
ment of immune mechanisms in the pathogenesis. This in con-
junction with the well-documented risk conferred by maternal
infections and behavioral abnormalities in animal models (Patter-
son, 2009) would support an underlying immunopathology, but
the GWAS results implicating MHC genes have been criticized
for using intergenic single-nucleotide polymorphisms (SNPs) in
many cases – although the SNPs are assumed to be in linkage
disequilibrium with the encoded genes, this cannot exclude non-
coding RNA involvement in schizophrenia; moreover, the genic
SNPs that have shown signiﬁcant associations have not been thor-
oughly characterized in terms of their function (Gejman et al.,
2011). Associations have also been found between schizophre-
nia and the pro-inﬂammatory cytokines interleukin 1β (Xu and
He, 2010), interleukin 6 (Paul-Samojedny et al., 2010), and the
anti-inﬂammatory interleukin 10 (Bocchio Chiavetto et al., 2002),
further supporting the involvement of inﬂammatory pathways,
even if the pathomechanisms throughwhich these alleles inﬂuence
disease development are obscure.
Autism spectrum disorders share some of the problems of
schizophrenia: numerous preliminary gene associations have not
been replicated, and the pathobiology is uncertain and likely to
be heterogeneous. In this case, the evidence for a developmen-
tal defect is much clearer, given its early onset. This is reﬂected
in the functions of implicated genes. For instance, neuroligin
4 was identiﬁed in a family with X-linked mental retardation
and autism (Laumonnier et al., 2004). Neuroligins are thought
to function in presynaptic development, and they interact with
neurexins to regulate postsynaptic development (Dean and Dres-
bach, 2006) – neurexin 1 has also been associated with ASDs
(Kim et al., 2008) and schizophrenia (Rujescu et al., 2009),
consistent with hypotheses of abnormal synaptic development
in these disorders. Copy number variations and mutations in
SHANK2 and SHANK3, synaptic scaffolding genes, have been
linked to ASDs (Durand et al., 2007; Berkel et al., 2010), as
have K+ channel regulation associated genes such as DPP6 and
DPP10 (Marshall et al., 2008), all indicative of synaptic dysfunc-
tion in autism. Cell migration pathways have been implicated by
a genome-wide study for copy number variations, which pro-
duced signiﬁcant results for cell adhesion genes with presumptive
migratory functions including ASTN2 (Glessner et al., 2009).
CNTNAP2, another ASD risk gene (Arking et al., 2008), has
also been characterized as crucial for normal neuronal migra-
tion: CNTNAP2−/− mice show behavioral abnormalities, ectopic
neurons in the corpus callosum (indicative of defective migra-
tion) and reduced numbers of GABAergic interneurons among
other abnormalities (Peñagarikano et al., 2011). MeCP2, the gene
www.frontiersin.org June 2012 | Volume 3 | Article 50 | 11
Stolp et al. Etiology of neurodevelopmental disorders
affected in Rett syndrome featuring autism and other devel-
opmental defects, also impairs GABAergic transmission: mice
exhibit behavioral defects suggestive of ASD in both full KOs
and interneuron-speciﬁc KOs of MeCP2 (Chao et al., 2010).
Overall, it can be concluded that both autism and schizophre-
nia share developmental origins and synaptic dysfunction as their
main pathways, but these are not independent of environmental
inﬂuences (Harrison and Weinberger, 2005; Bill and Geschwind,
2009).
In autism and schizophrenia, immune regulating gene vari-
ants have also been heighted as disease risk factors. In particular
there are multiple lines of evidence linking variants in DRB1 alle-
les of the human leukocyte antigen (HLA) with both of these
neurodevelopmental conditions (Crespi and Thiselton, 2011). It
is hypothesized that these genetic variants contribute to disease
ontology through modulation of the normal immune signaling in
brain development. Inﬂammation during pregnancy has also been
linked to both these neurological disorders in epidemiology (see
below), indicating that genetic and environmental variations can
affect normal development, and leading to disease pathology.
INFLAMMATION
A variety of genes with known roles in the immune system have
recently been found in progenitor cells in the developing cortex.
Toll-like receptors are a group of pathogen recognition receptors,
that respond to bacteria (e.g., TLR2 and TLR4) and viral (e.g.,
TLR3) presence (Medzhitov,2007). These receptorsmediate a pro-
inﬂammatory response through NF-κB, and have also been found
to be activated by tissue damage. Two recent studies have shown
the constitutive expression of TLR2 and TLR3 in progenitor cells
within the ventricular zone in early and intermediate telencephalic
development (Lathia et al., 2008; Okun et al., 2010). In both cases
activation of the receptor causes a decrease in proliferation, but
in the case of TLR2 the absence of the constitutive presence, in
TLR2−/− mice, does not affect proliferation or differentiation of
progenitors (Okun et al., 2010), while in TLR3−/− mice there is an
increase in proliferation in the VZ and SVZ (Lathia et al., 2008).
The presence of these and other inﬂammatory mediating recep-
tors in the neural progenitor cells provide a potential mechanism
for recent observations of inﬂammatory induced damage to the
developing brain. Many studies have shown behavioral changes
following maternal immune activation during early gestation. The
pathology underlying these behavioral changes has been unclear;
however, our recent study has shown that maternal inﬂammation
induced at in the early phases of telencephalic development causes
decreased proliferation in the VZ (Stolp et al., 2011; Figure 5).
Part of the mechanism for this may be the activation of the TLRs,
although this interaction has not yet been described. What has
been reported is a decrease in β-catenin at the ventricular surface
(Stolp et al., 2011),whichmay also contribute to the decreased pro-
liferation in this model, and suggests that a complex interplay of
many factors that normally regulate proliferation may be affected
by maternal inﬂammation. Interestingly, the maternal inﬂamma-
tory response that produces reduced ventricular proliferation at
E13.5 in the mouse does not appear to signiﬁcantly affect the pro-
liferation of basal progenitors within the SVZ (Stolp et al., 2011;
Figure 5). This suggests that the regulation of proliferation in the
SVZ may be different from theVZ, or that the mechanism of entry
of inﬂammatory molecules into the brain may selectively affect
one population and not the other. The basal progenitors in the
SVZ are closely associated with the blood vessels that make up
the ventricular vascular plexus in early development, while the VZ
progenitors have close contact with the CSF in the ventricular sys-
tem. In the adult brain, systemic inﬂammation has been found
to alter transcription of acute phase proteins and adhesion mole-
cules in the choroid plexus and there is an increase in interleukin-6
and the chemokine CCL2 in the CSF (Marques et al., 2009). It is
possible, though currently unstudied, that systemic inﬂammation
may also cause increased cytokine levels in fetal CSF that directly
regulate proliferation in the VZ.
Analternativemechanism for inﬂammatory regulationof prog-
enitor proliferation is a modiﬁcation in the normal function
of microglia. The work of Roumier et al. (2008) suggests that
inﬂammatory activation has the same effect as microglial loss-
of-function in the DAP12KI mouse. They provide evidence to
suggest that the loss-of-function mutation actually causes minor
activation of the microglia and cytokine production that modu-
lates neuronal function, which can be recapitulated at E15 in the
mouse by inducedmaternal inﬂammation. In the developing brain
microglia have a typically amoeboid morphology associated with
their entry from the systemic circulation and subsequent differen-
tiation. It has been hypothesized that this morphology conveys a
reactive phenotype and that inﬂammation or injury in the devel-
oping brain may be more severe than in the adult brain, where
microglia need to be reactivated from a “resting” state. At later
stages of brain development inﬂammation has been associated
with interneuron dysfunction. For instance, neonatal exposure
to LPS is associated with reduced parvalbumin immunoreactiv-
ity in the CA1–CA3 region (but not the prefrontal cortex) with
later defects in object recognition (Jenkins et al., 2009), and viral
infection at P4 can cause a gradual loss of hippocampal interneu-
rons (Pearce et al., 2000). Such changes can have an indirect effect
on the cortex: one recent study showed that neonatal intrahip-
pocampal LPS in rat increases cytokine expression in the adult
hippocampus and cortex, impairs dopaminergic modulation of
prefrontal interneurons and causes a deﬁcit in prepulse inhibi-
tion (Feleder et al., 2010). Inﬂammation during fetal development
has been most strongly linked with brain damage leading to cere-
bral palsy. Many studies have shown that maternal inﬂammation
in the later part of the second trimester, or equivalent in animal
models, causes an array of white matter injury, including diffuse
demyelination and cystic lesions (Rezaie and Dean, 2002), which
correspond well to the periventricular leukomalacia that is a com-
mon MRI observation in cerebral palsy (Counsell et al., 2003).
It seems that the susceptibility of the white matter to damage is
largely due to the presence of pre-oligodendrocytes that have a low
damage threshold (Back and Rivkees, 2004).
As one of the links between immune and CNS development,
there is a plethora of evidence for various cytokines regulating
CNS development. For instance, CSF-1 is a cytokine involved in
monocyte survival and proliferation, but nullmutations also cause
defects in cortical circuitry (Michaelson et al., 1996). The gp130
family cytokines such as LIF and CTNF promote radial glial cell
renewal and ventricular zone proliferation in rodents (Deverman
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FIGURE 5 | Effect of maternal inflammation on the ventricular zone at
E13. Maternal inﬂammation at E13 has profound effects on cortical
development. There is a decrease in proliferation in the ventricular zone
(A,B). As well as this, there is a disruption of the ventricular surface,
indicated by decreased β-catenin immunoreactivity (C,D) and uptake of
proteins from the CSF (E,F), by acetylated tubulin positive radial glia (G).
Scale bars=50μm for (A–F), 10μm for (G). Modiﬁed from Stolp et al.
(2011).
and Patterson, 2009), but also astrogliogenesis in later develop-
ment. However, this is mainly related to local expression within
the developing CNS, rather than the inﬂammation-associated
endocrine functions of cytokines,which have been associated with
a wide variety of neurodevelopmental disorders including schiz-
ophrenia (Ellman and Susser, 2009), autism and periventricular
leukomalacia (Deverman and Patterson, 2009). Due to the preva-
lence of IL-6/gp130 family cytokines acting in the developing
brain, there has been substantial investigation of the contribution
of IL-6 of brain injury induced by maternal immune activation.
IL-6 has been shown to increase in the fetal brain following many
forms of early life systemic inﬂammation (Golan et al., 2005; Stolp
et al., 2009), and there is some evidence that IL-6 in the maternal
circulation can cross the placenta from mid-gestation (Dahlgren
et al., 2006). The most compelling evidence for the important
contribution of IL-6 to early life neurodevelopmental disorders
is the work of Patterson and colleagues. In their recent paper
(Smith et al., 2007), substantial evidence was present that IL-6
alone could stimulate long-term changes in neurological behav-
ior and that inhibiting IL-6 when inﬂammation is induced by a
general immune mediator prevents these behavioral phenotypes.
A further recent study also implicated maternal IL-6 in inﬂuenc-
ing placental expression of immune- and endocrine-related genes,
including factors known to inﬂuence fetal development such as
growth hormone and insulin-like growth factor I (Hsiao and Pat-
terson, 2011), which poignantly illustrates the interconnectedness
of immune, endocrine, and CNS development.
HYPOXIA-ISCHEMIA
While the brain grows in a hypoxic environment, it is protected
from extremes of hypoxia, as with many other organs, by vascular
auto-regulation (Pearce, 2006). As part of normal brain func-
tion, neurovascular coupling allows distribution of nutrients in
a spatial and temporal fashion to brain areas with the highest
neuronal activity and, therefore, metabolic demand. This form of
auto-regulation is typically due to the function of smooth mus-
cle cells around the pial, penetrating and pre-capillary arterioles
(Lok et al., 2007). However, at the level of the capillaries, per-
icytes and astrocytes have been found to have some contractile
capacity and are able to regulate vessel diameter (Haydon and
Carmignoto, 2006; Peppiatt et al., 2006). It is currently unclear
how much this contributes to the vascular auto-regulation (dis-
cussed by Quaegebeur et al., 2011), and there is also currently
limited data indicating when these auto-regulatory mechanisms
are established. Clinical and experimental research demonstrated
evidence of regulation during late stages of human pregnancy and
pericyte- and astrocyte-induced contraction of capillary beds in
postnatal rat brains (Peppiatt et al., 2006; Degani, 2009), suggest-
ing that auto-regulatory mechanisms occur in the fourth phase of
telencephalic development.
Hypoxic injury is generally considered to be associated with
birth complications and neurodevelopmental injury such as cere-
bral palsy (Gunn and Bennet, 2009; Volpe, 2009). There has been
a recognized difﬁculty in diagnosing consequences of antena-
tal oxygen deprivation as there is not a clear correlation with
markers of oxygen deﬁcit (e.g., acidosis, lactate levels) and later
neuropathology (Gunn and Bennet, 2009). This is partly due to
the protective mechanism of the brain and cerebrovascular sys-
tem and the regenerative capacity of the still developing CNS (see
below). However, despite the presence of auto-regulatory mecha-
nisms, the clearest link between hypoxia-ischemia and brain injury
is during this stage of brain development (Lou et al., 2004). White
matter damage has been found to occur following inﬂamma-
tion or hypoxia-ischemia (Hagberg et al., 2002). The precursor
oligodendrocytes are susceptible to damage at this stage of devel-
opment (Back et al., 2001; Back and Rivkees, 2004) and a number
of studies have shown that high density of microglia within the
white matter contributes to this injury, facilitating the immune
activation of the susceptible oligodendrocyte precursors (Verney
et al., 2010). It is likely that the mechanisms of injury in these
two experimental conditions are linked, as hypoxia-ischemia can
cause the production of inﬂammatory mediators and inﬂamma-
tion can cause an alteration in auto-regulation and potentially
reduce oxygenation.
Astrocytes have been shown to undergo functional and struc-
tural long term changes following neonatal hypoxia/ischemia
in the pig brain (Sullivan et al., 2010a,b). There are sig-
niﬁcant decreases in the average astrocyte size, number of
processes, and length of processes following hypoxia-ischemia
treatment. Furthermore, d-aspartate uptake studies revealed that
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the hypoxia-ischemia insult resulted in impaired astrocytes func-
tion, with signiﬁcantly reduced clearance of the glutamate analog,
d-aspartate. Sullivan et al. (2010b) argue that the initial reduction
in astrocytes size and impaired function in the study are detri-
mental to the survival of neurons. Changes in the morphology of
astrocytes have the potential to alter functions reliant on the loca-
tion of astrocytic membrane proteins, for example the glutamate
transporters located in close proximity to synapses play a role
in clearing the excitatory amino acids preventing excitotoxicity
(Sullivan et al., 2010b).
Subplate neurons have been suggested to be selectively sensitive
to hypoxic-ischemic injury in postnatal rodents (McQuillen et al.,
2003) and perinatal humans (Volpe, 2009) that might account
for some behavioral deﬁcits observed following hypoxic-ischemic
injury. However, the majority of thalamic connections have been
made by these stages of brain development, and no damage
to these connections was observed following injury (McQuillen
et al., 2003). It has recently been questioned whether the sub-
plate is actually at increased sensitivity that other neurons in the
cerebral cortex (Nguyen and McQuillen, 2010), with deﬁcits in
layer V also observed in autopsy studies of human periventricular
leukomalacia (Andiman et al., 2010).
DRUGS/TOXINS
Unlike the relatively general actions of inﬂammation and hypoxia,
a number of drugs and toxins appear to have very speciﬁc actions
on the central nervous system, based on binding to channels or
receptors within the brain. Lead is one example of this, where its
presence within the brain appears to interfere with Ca2+ entry
into synaptic terminals, which normally facilitates neurotransmit-
ter release (Suszkiw, 2004). Interestingly, this appears to have an
immediate effect, as well as a long-term, developmental effect.
This may be due to the inhibition of NMDA receptor-dependent
BDNF signaling, that is important for the stabilization of synaptic
regions during presynaptic development (Neal et al., 2010). The
CB1-receptor is differentially regulated during neurogenic com-
mitment, and there is evidence suggesting that cannabis exposure
can affect fate regulation of cells in the developing brain by switch-
ing the balance of normal endocannabinoid signaling (Keimpema
et al., 2011). Cocaine exposure during the prenatal period appears
to have long term consequences on dopamine transporter func-
tion (Harvey, 2004) as well as impairing tangential and radial
migration within the developing telencephalon (Lee et al., 2011;
McCarthy et al., 2011), providing a possible double-hit that results
in long-term behavioral deﬁcits.
Ethanol is another environmental toxin with known effects
on the central nervous system, and is currently considered to
be the major preventable cause of mental retardation world-
wide (Centre of Disease Control). In the cortex, observed changes
include ectopias andmicrogyri-like structures and a general reduc-
tion in cortical volume (see Fukui and Sakata-Haga, 2009 for
review). These changes, and the critical period identiﬁed for
ethanol-induced microcephaly (Guerri, 2002), suggest early stages
of cortical development are disrupted, with the radial progeni-
tors the main target for the effects of ethanol. In support of this
hypothesis, a decrease proliferation of these progenitors has been
observed in a number of models of prenatal ethanol exposure
(Rubert et al., 2006), as well as increased death of this population
(Rubert et al., 2006; Aronne et al., 2008). There is also a reduc-
tion in the ability of the radial progenitors to differentiate into
neurons and glia in an ex vivo assessment of progenitor func-
tion following prenatal ethanol exposure (Rubert et al., 2006).
Interestingly, a recent study suggests that alcohol induces inﬂam-
mation via activation of TLR4 (Alfonso-Loeches et al., 2010),
which could mean that inﬂammation and ethanol exposure have
similar underlying mechanisms of damage in the early developing
brain.
GENE-ENVIRONMENT INTERACTIONS
The original evidence supporting gene-environmental interac-
tions in neurodevelopmental disorders were based largely on
observations of disease incidence. For example, siblings of autis-
tic patients have approximately a 3–8% risk of disease incidence.
This risk increases to 10% in non-identical twins and to 60–90%
in identical twins (Parker-Athill and Tan, 2010). The incidence
in siblings suggests a genetic component of the disease, while the
increased incidence in non-identical twins highlights the impor-
tant contribution of a shared maternal environment. The high
concordance in identical twins, where gene and maternal envi-
ronment are shared, has now been recognized not just to indicate
genetic susceptibility, but also to highlight the important of the
gene-environment interaction (van Os et al., 2010).
There are two main mechanisms by which gene-environment
interactions can contribute to disease etiology. The ﬁrst is a direct
interaction, where a genetic polymorphism or copy number vari-
ant increases damage (or confers protection) after an environ-
mental insult. The second is the ability of an environmental insult
to produce an epigenetic change, potentially causing a long-term
modulation of gene function (Van Winkel et al., 2010). There is
evidence for both of these interaction paradigms in a number of
neurological and mental disorders.
There are, as yet, few experimental studies testing the link
between genes and environment, although those that do, using
a number of outcome measures, have all indicated a synergistic
effect of genetic modiﬁcation is combined with environmental
challenge, above and beyond what was observed with a single
challenge (Oliver, 2011). One example, relevant for the etiology
of schizophrenia is the combination of early life inﬂammation
and a DISC1 mutation, which has been recognized in a number
of schizophrenic patients. PolyI:C induced inﬂammation in both
prenatal and postnatal mice carrying a DISC1 mutation is associ-
ated with a number of behavioral changes that are not observed in
the DISC1 animals or polyI:C animals alone (Abazyan et al., 2010;
Ibi et al., 2010).
The neurodevelopmental injury models of schizophrenia have
also lead to the identiﬁcation of new candidate genes for increased
disease risk. Considering the increased risk of schizophrenia asso-
ciated with perinatal hypoxia, Schmidt-Kastner et al. (2012) re-
evaluated a number of GWAS and CNV studies to determine if
genes associated with the hypoxic-ischemic response are altered
in the schizophrenic patients. Their ﬁndings substantially sup-
ported this hypothesis, identifying a number of additional gene
modiﬁcations that may increase the risk of schizophrenia fol-
lowing birth complications, and supporting the earlier work of
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Nicodemus et al. (2008), who showed a signiﬁcant interaction
between hypoxia-ischemia genes and obstetric complications in
a cohort of schizophrenia patients.
A later life example of gene-environment interaction is that of
the association between cannabis use and psychosis. Caspi et al.
(2005) conducted a longitudinal study on an epidemiological birth
cohort and found that presence of a polymorphism in the COMT
gene in combination with adolescent cannabis use increased the
risk of adult-hood psychosis. The presence of the polymorphism
explains the strong associationbetween cannabis use andpsychosis
while also accounting for the small risk of psychosis in cannabis
users in general.
Epigenetic changes in neurological disease are less well deﬁned
in neuropathology, and the potential heritability of the epigenetic
change confounds the gene-environment calculation. However,
altered histone methylations (one of the key forms of epige-
netic regulation) have been described in brains from patients that
had been diagnosed with schizophrenia or depression (Peter and
Akbarian, 2011). Drug exposure (e.g., to methamphetamine) and
stress are examples of environmental challenges that my cause epi-
genetic changes, and have been linked to changes in DNA methy-
lation in the brains of schizophrenic patients and relevant ani-
mal models (Oh and Petronis, 2008). Additionally, transcriptional
repressorMeCP2has been identiﬁed in autism,with gene silencing
produced by this mechanism linked to changes in neuronal struc-
ture (Currenti, 2010). It is likely that epigenetic modiﬁcation of
gene function will be increasingly recognized as a key contributor
to neurological disorders as our scientiﬁc investigations continue
in this area.
CONCLUSIONS
It is clear that there are a number of factors that contribute to
neurodevelopmental disorders. When considering which are the
most important in predicting neuropathology following insult it
is necessary to consider the likelihood that multiple “windows of
vulnerability” exist within the developing brain. These are likely to
be dependent on the type and severity of the environmental insult
and the genetic background of the individual. The task to decipher
the links between genetic susceptibility and environmental insults
is hindered by the fact that barrier functions, inﬂammatory, and
endocrine factors have to be taken into account along with brain
development. These will have to be considered in different com-
binations, rather than in isolation. Our current approaches are
not broad enough. We are determined to link diseases to a single
genetic or environmental insult. Instead, a wide variety of broadly
linked functional systems have been identiﬁed as possibly effected,
and the genes involved in various stages of neuronal development
might be just a small part of the puzzle.
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